Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Ironwood Pharmaceuticals, Inc.
Type
Public
Traded as NASDAQ:IRWD
Industry Biofuels And Bioproducts Industry
Founded 1998
Headquarters Cambridge, Massachusetts.
Products Bioproducts
Website www.ironwoodpharma.com

Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031. The company is publicly listed on NASDAQ with the symbol "IRWD".

In 2008, Microbia, Inc. changed its name to Ironwood Pharmaceuticals, Inc.

This principal product of Ironwood Pharmaceuticals was approved by the US FDA in August 2012, and reached the US market in December 2012. The drug is focused on treating irritable bowel syndrome and related symptoms, which according to the National Institutes of Health (NIH) affects around 20% of Americans. Linaclotide is estimated to reach blockbuster status in around the year 2021, based on the forecast of market research firm Decision Resources.

The company is also doing research on treatment for painful disorders of the small intestine, and has an early-stage product called IW-9179. The drug has just passed Phase 2a study in 2013, and showed effects in treating Functional Dyspepsia (FD).

BNC210 is an anxiolytic that Ironwood licensed and performed R&D on. It was abandoned November 2014.

In February 2014, Ironwood Pharmaceuticals was issued allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031. The patented method aims at achieving stable condition of the drug at room temperature and can dissolve in stomach with capsule and suitable for oral dosing. This is another step forward in research and experiments based on Linaclotide usage.

Investment goal date:
Dividends reinvested
Ironwood Pharmaceuticals, Inc. IRWD report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-07
--
--
Q4 2017
2018-02-19
--
--
Q3 2017
2017-11-02
-0.1800
0.0000
Q3 2017
2017-11-01
0.0000
0.0000
Q2 2017
2017-08-03
-0.2800
-0.3000
Q1 2017
2017-05-08
-0.3600
-0.3600
Q4 2016
2017-02-21
-0.0900
-0.0900
Q3 2016
2016-11-03
-0.2300
-0.2300
Q2 2016
2016-08-04
-0.1500
-0.1500
Q1 2016
2016-05-09
-0.0900
-0.0900
Q4 2015
2016-02-18
-0.0900
-0.0900
Q3 2015
2015-11-03
-0.3300
-0.3300
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ADAGE CAPITAL PARTNERS GP LLC
5950000
BlackRock Fund Advisors
6452010
BlackRock Inc.
11368314
BlackRock Institutional Trust Company, N.A.
3548966
BROWN CAPITAL MANAGEMENT LLC
5091074
EcoR1 Capital, LLC
2905515
FMR LLC
19378846
JANUS CAPITAL MANAGEMENT LLC
7925901
ORBIMED ADVISORS LLC
7241300
PICTET ASSET MANAGEMENT LTD
1631192
PRICE T ROWE ASSOCIATES INC /MD/
16306543
SECTOR GAMMA AS
1940778
STATE STREET CORP
3984803
Vanguard Group, Inc
10505461
WELLINGTON MANAGEMENT CO LLP
18581554
Major Shareholders
Name Relationship
Total Shares
Holding stocks
FMR LLC
0.6900% (837736)
VENROCK ASSOCIATES
2.2900% (2762497)
IRWD /
COOK JOSEPH C JR
0.2500% (304080)
CORT / IRWD /
CONRADES GEORGE H
0.0500% (62221)
AKAM / HOG / IRWD / ORCL /
MCGUIRE TERRANCE
0.0500% (60476)
IRWD / RTGN / TRVN / XLRN /
WALSH CHRISTOPHER T PHD
0.0600% (71499)
AKAO / IRWD /
WILLIAMS DOUGLAS E
0.0600% (75633)
EBERSMAN DAVID A
0.0200% (29714)
CSLT / FB / IRWD /
OLANOFF LAWRENCE S
0.0300% (33330)
FRX / IRWD /
ROBERTS BRYAN E
0.0300% (31951)
Fanucci Marsha
0.0600% (75633)
ALNY / IRWD / MNTA /
SCHULMAN AMY W
0.0200% (25418)
ALNY / BIND / IRWD /
Currie Mark G
0.6400% (775000)
IRWD /
Hecht Peter M
3.8900% (4703316)
IRWD /
Higgins Michael J
0.2700% (329102)
GNCA / IRWD / RTGN /
Shaw David Evans
0.0500% (64306)
IRWD /
VHCP Co-Investment Holdings, LLC
0.0200% (18910)
IRWD /
McHugh Julie
0.0700% (80908)
Consylman Gina
0.0400% (52001)
ALOG / IRWD /
Consylman Gina
0.0400% (52865)
ALOG / IRWD /
Owens Edward P
0.1500% (183305)
IRWD /
Graney Thomas
0.0300% (42013)
IRWD / VRTX /
% ()